TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nobel Biocare AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 376,622 | 357,850 | 266,201 |
Financial expenses | 19,101 | 12,235 | 3,312 |
Earnings before taxes | 22,807 | 9,086 | 3,286 |
EBITDA | 67,491 | 40,132 | 23,081 |
Total assets | 948,609 | 1,692,231 | 0 |
Current assets | 256,678 | 933,773 | 580,327 |
Current liabilities | 142,111 | 833,852 | 452,759 |
Equity capital | 797,562 | 848,598 | 857,163 |
- share capital | 211,954 | 230,636 | 235,086 |
Employees (average) | 364 | 350 | 296 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 84.1% | 50.1% | |
Turnover per employee | 1,035 | 1,022 | 899 |
Profit as a percentage of turnover | 6.1% | 2.5% | 1.2% |
Return on assets (ROA) | 4.4% | 1.3% | |
Current ratio | 180.6% | 112.0% | 128.2% |
Return on equity (ROE) | 2.9% | 1.1% | 0.4% |
Change turnover | 47,758 | 96,688 | -24,435 |
Change turnover % | 15% | 37% | -8% |
Chg. No. of employees | 14 | 54 | 3 |
Chg. No. of employees % | 4% | 18% | 1% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.